FDA approves Respironics product for complex apnea

Saturday, March 31, 2007

MURRYSVILLE, Pa. - ResMed is no longer the only company to have an FDA approved product--VPAP Adapt SV--for the treatment of complex sleep apnea. In early March, the FDA granted 510(k) clearance for Respironics BiPAP autoSV device to be used for that same purpose. Patients with complex sleep apnea exhibit OSA but demonstrate persistent central sleep apnea. Until recently, doctors have treated patients with central sleep apnea, usually unsatisfactorily, with bilevel devices, which are intended primarily for non-compliant OSA patients and for people suffering from neurological disorders, Mick Farrell, ResMed's vice president of marketing, told HME News in October 2006.